Alvis Brazma1, Pascal Hingamp2, John Quackenbush3, Gavin Sherlock4, Paul Spellman5, Chris Stoeckert6, John Aach7, Wilhelm Ansorge8, Catherine A. Ball4, Helen C. Causton9, Terry Gaasterland10, Patrick Glenisson11, Frank C.P. Holstege12, Irene F. Kim4, Victor Markowitz13, John C. Matese4, Helen Parkinson1, Alan Robinson1, Ugis Sarkans1, Steffen Schulze-Kremer14, Jason Stewart15, Ronald Taylor16, Jaak Vilo1
& Martin Vingron171
European Bioinformatics Institute, EMBL outstation, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
2
Centre d'Immunologie de Marseille Luminy (CIML TAGC) & Université de la Méditerranée, Marseille, France.
3
The Institute for Genomic Research (TIGR), Rockville, Maryland, USA.
4
Stanford University, Palo Alto, California, USA.
5
University of California Berkeley, Berkeley, California, USA.
6
University of Pennsylvania, Philadelphia, Pennsylvania, USA.
7
Department of Genetics, Harvard Medical School, Cambridge, Massachusetts, USA.
8
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
9
CSC/Imperial College School of Medicine Microarray Centre, London, UK.
10
Rockefeller University, New York, New York, USA.
11
Katholieke Universiteit Leuven, Leuven, Belgium.
12
University Medical Center, Utrecht, Netherlands.
13
GeneLogic Inc, Gaithersburg, Maryland, USA.
14
RZDP German Genome Resource Center, Berlin, Germany.
15
Open Informatics, Albuquerque, New Mexico, USA.
16
Center for Computational Pharmacology, University of Colorado School of Medicine, Denver, Colorado, USA.
17
Max Plank Institute for Molecular Genetics, Berlin, Germany.
Correspondence should be addressed to Alvis Brazma brazma@ebi.ac.uk or John Quackenbush johnq@tigr.org
